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 Abstract 
 Background: Thrombocytopenia is the most common 
coagulation disorder in critically ill patients. No studies 
have investigated the epidemiology and clinical impact of 
this condition in emergency department (ED) patients. We 
aimed to investigate epidemiological features, incidence 
of bleeding, and diagnostic and therapeutic requirements 
of patients with thrombocytopenia admitted to the ED. 
 Methods: We performed a retrospective observational 
study enrolling all patients admitted to the medical-surgi-
cal ED of the  “ Citt à della Salute e della Scienza di Torino ” 
Hospital with a platelet count  < 150 × 10 9 PLTs/L, during 
four non-consecutive months. There were no exclusion 
criteria. 
 Results: The study included 1218 patients. The percentage 
of patients with severe ( < 50 × 10 9 PLTs/L) or very severe 
( < 20 × 10 9 PLTs/L) thrombocytopenia was about 12%. 
Thrombocytopenia associated with liver cirrhosis was the 
most represented etiology. On the contrary, the most fre-
quent cause in patients with newly recognized low platelet 
count was disseminated intravascular coagulation/sepsis. 
The incidence of bleeding and hypovolemia, as well as the 
need of transfusional support and mechanical, surgical or 
endoscopic hemostasis progressively increased with the 
severity of thrombocytopenia. 
 Conclusions: Our results suggest that the detection of a 
platelet count lower than 50 × 10 9 PLTs/L may help to iden-
tify patients with higher bleeding risk in the ED setting. 
Additional studies are required to evaluate whether, in 
this setting, thrombocytopenia may represent an inde-
pendent risk factor for bleeding episodes and increased 
mortality. 
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 Introduction 
 Thrombocytopenia is the most common coagulation 
disorder in critically ill patients  [1] . Low platelet (PLT) 
count, even though not associated with bleeding, influ-
ences patient management and treatment decisions  [2] . 
Thrombocytopenia, indeed, often prompts physicians to 
reassess timing of invasive interventions, anticoagulation 
intensity, and may also leads to prophylactic PLT trans-
fusion for correction of PLT count values  [2] . Moreover, 
thrombocytopenia, usually defined as a PLT count lower 
than 150 × 10 9 PLTs/L  [3, 4] , has been proven an independ-
ent risk factor for both longer intensive care unit (ICU) 
length of stay  [3, 5 – 7] and higher mortality in critically ill 
patients  [3, 5 – 8] . Finally, although illness severity scoring 
systems inconsistently consider PLT count, ICU patients 
with thrombocytopenia have illness severity scores, such 
as MODS or APACHE-II higher than those without throm-
bocytopenia  [6, 7] . 
 Whereas thrombocytopenia is of common occurrence 
in patients entering the emergency department (ED), no 
studies specifically investigated the epidemiology and 
clinical impact of this condition in ED patients. Only 
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a previous observational study, conducted on a small 
patient cohort of 115 ED patients, reported an incidence 
value of about 10%  [9] . 
 The aim of this study was to investigate epidemiologi-
cal features, incidence of bleeding, and diagnostic and 
therapeutic requirements of patients with thrombocyto-
penia admitted to the ED. 
 Materials and methods 
 We performed a retrospective observational study enrolling all 
patients admitted to the medical-surgical ED of the  “ Citt à della Salute e 
della Scienza di Torino ” Hospital with a PLT count  < 150 × 10 9  PLTs/L, 
during four non-consecutive months (January, April, July, October, 
2012). There were no exclusion criteria. 
 We classifi ed the severity of thrombocytopenia as mild, mod-
erate, severe, or very severe on the basis of PLT count  < 150 × 10 9 
PLTs/L,  < 100 × 10 9 PLTs/L,  < 50 × 10 9 PLTs/L, or  < 20 × 10 9 PLTs/L, 
respectively, according to a previously published study  [7] . 
 Data we collected included demographic data, co-morbidities, 
drugs used in the last 2-week period before admission, HIV infec-
tion, most recent PLT count before admission (within 6 months), and 
ED admission category. In addition, we recorded the occurrence of 
bleeding, packed red blood cell (PRBC) and PLT transfusion require-
ment, and the need to perform surgical/endoscopic mechanical 
hemostasis, or hematologic consultation. 
 We considered major bleeding episodes those that caused drop 
in hemoglobin values  > 2 g/dL, those requiring mechanical hemostasis 
or PRBC transfusions within 24 h, and all intracranial hemorrhages. 
 The etiology of thrombocytopenia was derived by medical 
records. 
 The study was conducted according to the Helsinki Declaration, 
and approved by our Institutional Ethical Committee. 
 Results 
 During the study period, we enrolled 1218 patients admit-
ted to our ED with a PLT count  < 150 × 10 9 PLTs/L.  Table 1 
gives demographic and clinical data of patients. 
 Most patients were of older age (median ± SD 
69.00 ± 17.7 years; range 14 – 99 years), and required ED 
evaluation related to a non-surgical admission category 
(75.9%). In only 2.8% of all patients, the major clinical 
problem leading to ED evaluation was directly associ-
ated with thrombocytopenia, in particular, the occurrence 
of petechiae and minor or major bleeding episodes in 
patient with no other hemorrhagic diathesis. In addition, 
patients were generally affected by more than two associ-
ated pathologies. 
 Most of the patients ( > 85%) had mild or moderate 
thrombocytopenia, whereas the percentage of patients 
 Table 1   Demographic and clinical characteristic of patients. 
Sex, M/F (% males)   830/388 (67.4%) 
Age, median ± SD (range)   69.00 ± 17.7 (14 – 99)
Medical admission, n (%)   925 (75.9%)
Admission category, %  
   Strictly related to thrombocytopenia  34 (2.8%)
   Pneumologic   109 (8.9%)
   Cardiovascular   170 (14.1%)
   Gastrointestinal   196 (16.1%)
   Hepatic   140 (11.4%)
   Neurologic   93 (7.6%)
   Sepsis   102 (8.4%)
   Orthopedic   70 (5.7%)
   Ematologic   39 (3.2%)
   Nephro-urologic   108 (8.9%)
   Other   157 (12.8%)
Comorbidities, mean ± SD   2.22 ± 1.28
Platelet count at admission  
   101 – 150 × 10 9 PLTs/L, n (%)   794 (65.3%)
   51 – 100 × 10 9 PLTs/L, n (%)   277 (22.7%)
   21 – 50 × 10 9 PLTs/L, n (%)   99 (8%)
   < 20 × 10 9 PLTs/L, n (%)   48 (4%) 
with severe or very severe thrombocytopenia was slightly 
above 12%.  Table 2 lists the causes of thrombocytopenia 
found in the study cohort. 
 Thrombocytopenia associated with liver cirrhosis 
was the most represented cause of thrombocytopenia, 
accounting for about 1/5 of all patients. On the contrary, 
in patients with newly recognized low PLT count, the 
most frequent cause was represented by thrombocytope-
nia associated to disseminated intravascular coagulation 
(DIC)/sepsis. 
 In the half of cases, the cause of thrombocytopenia 
was either unspecified or not investigated during the hos-
pital stay; however, the great majority of these patients 
 Table 2   Etiology of thrombocytopenia. 
Liver cirrhosis, n (%)   248 (20.4%) 
Blood cancers (leukemia, lymphoma, multiple 
myeloma), n (%)
  126 (10.3%)
Chemotherapy-induced thrombocytopenia, n (%)  68 (5.6%)
Immune thrombocytopenia, n (%)   44 (3.6%)
Disseminated intravascular coagulation (DIC)/
Sepsis, n (%)
  41 (3.3%)
Drug-associated thrombocytopenia, n (%)   24 (1.9%)
Post-viral illness thrombocytopenia, n (%)   24 (1.9%)
Solid cancers, n (%)   20 (1.7%)
Autoimmune diseases, n (%)   9 (0.7%)
Thrombotic thrombocytopenic purpura, n (%)   2 (0.2%)
Pseudothrombocytopenia, n (%)   2 (0.2%)
Unspecified, n (%)   610 (50.1%) 
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(89.8%) presented with mild or moderate thrombocyto-
penia, and none with severe or very severe thrombocyto-
penia. Only few patients were submitted to bone marrow 
aspiration/biopsy during the hospital stay, none of them 
in the ED. 
 Table 3 gives the incidence of bleeding according to 
the severity of thrombocytopenia. A total of 137 patients 
(11.2%) experienced a bleeding episode, of whom 53 
were categorized as major bleedings. As expected, the 
incidence of bleeding and of hypovolemia was higher in 
patients with lower PLT count. 
 Table 4 shows the therapeutic/diagnostic inter-
ventions performed during the ED stay according to 
thrombocytopenia severity. The need of PRBC and PLT 
transfusions, mechanical hemostasis interventions, and 
hematologic consultations increased with the severity of 
thrombocytopenia. 
 Discussion 
 This is the first study aimed to investigate the epidemio-
logical features, the incidence of bleeding, and the diag-
nostic and therapeutic requirements of patients with 
thrombocytopenia admitted to the ED. Previous studies 
investigated the incidence and prognostic impact of 
thrombocytopenia in ICU  [3, 6 – 8, 10] or onco-hematologic 
patients  [11 – 14] . However, these patient populations are 
very different from patients admitted to the ED, making it 
very difficult to extrapolate the results coming from these 
studies to the ED setting. 
 The most innovative result of our study is the demon-
stration that patients with severe or very severe thrombo-
cytopenia ( < 50 × 10 9 PLTs/L), although accounting for only 
about 12% of all thrombocytopenic ED patients, experi-
enced major bleeding episodes in a significantly larger per-
centage (17/137 patients, 11.5%) compared to patients with 
less severe thrombocytopenia (36/1071 patients, 3.4%). 
In addition, the management of ED patients with lower 
PLT counts required the employment of more diagnostic 
resources and therapeutic interventions, as indicated by 
the higher need of PRBC (22.4%) and PLT (25.2%) transfu-
sions, mechanical hemostasis interventions (10.9%), and 
hematologic consultations (38.1%). 
 Demographic characteristics of our study cohort were 
heterogeneous. The advanced age, the variety of admis-
sion categories, and the high number of comorbidities 
make our study population representative of the complex-
ity of patients entering a big inner city ED. 
 The etiology of thrombocytopenia in our study 
cohort was also very heterogeneous. Most of our knowl-
edge in this field is based on studies performed in onco-
hematological patients in stable conditions, in whom 
central thrombocytopenia, due to reduced bone marrow 
thrombopoiesis, has been shown the main mechanism 
responsible for low PLT count  [11 – 14] . On the contrary, in 
critically ill patients admitted in the ICU, thrombocytope-
nia is more often caused by increased PLT consumption, 
mainly consequent to the development of sepsis and/or 
DIC  [10, 15] . Interestingly, in critically ill patients, the rela-
tionship between thrombocytopenia and bleeding risk is 
less stringent than in onco-hematologic patients  [6, 7] , 
 Table 3   Incidence of bleeding according to thrombocytopenia severity. 
 
 
 
 
Mild 
(101 – 150 × 10 9 ) 
 
 
Moderate 
(51 – 100 × 10 9 ) 
 
 
Severe 
(21 – 50 × 10 9 ) 
 
 
Very severe 
( < 20 × 10 9 ) 
Pethechiae, % (n)   3.4% (37)   12.6% (35)   33.3% (33)   54.2% (26)
Minor bleedings, % (n)  6.3% (50)   7.6% (21)   8.1% (8)   41.7% (20)
Major bleedings, % (n)   3.0% (24)   4.3% (12)   9.1% (9)   16.7% (8)
Hypovolemia, % (n)   1.8% (14)   4.3% (12)   7.1% (7)   8.3% (4) 
 Table 4   Therapeutic/diagnostic intervention requirement according to thrombocytopenia severity. 
 
 
  Mild 
(101 – 150 × 10 9 ) 
  Moderate 
(51 – 100 × 10 9 ) 
  Severe 
(21 – 50 × 10 9 ) 
  Very severe 
( < 20 × 10 9 ) 
PRBC transfusion   3.8% (30)   6.5% (24)   24.2% (18)   31.9% (15)
PLT transfusion   0.4% (3)   1.8% (5)   8.1% (8)   61.7% (29)
Endoscopic hemostasis   2.1% (17)   3.6% (10)   5.0% (5)   14.9% (7)
Surgical hemostasis   0.6% (5)   0% (0)   2.0% (2)   4.4% (2)
Hematologic consultation   1.4% (36)   2.5% (37)   16.1% (25)   31.2% (31) 
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probably related to the preserved production of functional 
PLTs  [10, 16] . In our study, the most represented etiology 
was thrombocytopenia associated with liver cirrhosis; 
however, analogously to what is observed in ICU patients 
 [10, 15] , the first cause of low PLT count in patients with 
newly recognized thrombocytopenia resulted DIC/sepsis. 
 In our study, the cause of thrombocytopenia was 
either unspecified or not investigated during the hospital 
stay in about half of the patients. Since most of them had 
mild or moderate thrombocytopenia, and none had severe 
or very severe thrombocytopenia, therefore very low rate 
of bleeding complications, the attitude of ED physicians 
not to spend diagnostic and therapeutic resources on 
these patients seems to be appropriate. 
 Several limits have to be taken into account in inter-
preting our results. The retrospective design limits the 
information that can be obtained concerning possible 
etiologies for the thrombocytopenia, which remained 
unspecified in about 50% of the patients enrolled in our 
study. Moreover, the number of patients affected by severe 
or very severe thrombocytopenia was relatively low. 
Finally, we did not evaluate, in the present study, whether 
thrombocytopenia and the need for blood component 
transfusion correlate with mortality in the ED setting. 
Additional studies are required to evaluate whether 
thrombocytopenia may represent an independent risk 
factor for bleeding episodes and increased mortality. 
 In conclusion, our results suggest that the detection 
of a PLT count lower than 50 × 10 9 PLTs/L may contribute 
to identify patients with higher bleeding risk in the ED 
setting. 
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